Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
James Lewis
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The primary aim of the study is to examine the effect of rosiglitazone (Avandia) on gene regulation in colonic epithelium in the absence of pathologic acute and chronic intestinal inflammation. The secondary aims are to determine the effect of rosiglitazone (Avandia) therapy on T cell activation and cytokine expression in the absence of pathologic acute and chronic intestinal inflammation.
Age
18–40
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Capable of giving informed consent
Agrees to use a barrier method of birth control for the duration of the study
You may not be if
History of inflammatory bowel disease
Has taken prescription or over the counter medications in the two weeks prior to enrollment
History of diabetes, heart failure, angina, hypertension, coronary heart disease, cancer, bleeding disorder, HIV, AIDS
Fasting LDL \>160 mg/dl
History of smoking in the year prior to enrollment
Pregnant or breastfeeding
Clareo Health | Gene Regulation by Thiazolidinediones
